Frequently Asked Questions
The market is segmented based on , By Type (ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blocker, Diuretics, Others), Application (Injection, Capsule, Tablets), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End Users (Hospitals, Specialty Centres, Others) - Industry Trends and Forecast to 2030.
.
The Global Heart Failure Drugs Market size was valued at USD 8010.62 USD Million in 2023.
The Global Heart Failure Drugs Market is projected to grow at a CAGR of 15.56% during the forecast period of 2024 to 2030.
The major players operating in the market include Amgen, AstraZeneca, Bayer, Novartis, Gilead Sciences, GlaxoSmithKline, Pfizer, Teva Pharmaceutical Industries, Cardurion Pharmaceuticals, Cardior Pharmaceuticals, Actelion Pharmaceuticals, Boehringer Ingelheim International, BristolMyers Squibb, CYTOKINETICS, and Eli Lilly and Company.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
